Overview

Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)

Status:
Terminated
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
To test the effect of the research study drug, inhaled fluticasone on lung function in exercising patients with Chronic Obstructive Pulmonary Disease (COPD).
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Fluticasone